BPC -157 is a 15 amino acid partial sequence of Body protection compound that was discovered and isolated in gastric juice
Lupus patients on hydroxychloroquine, methotrexate, or biologics face unknown interaction risks with unregulated compounded peptides, making physician oversight non-optional before adding BPC-157 to any protocol
This cautious approach prevents unnecessary discomfort from applying potentially irritating products directly to delicate periorbital region, following peptide safety protocols minimizing risk
Beyond 30 days, gradual peptide degradation may occur
Siri-Angkul N, Xie LH, Chattipakorn SC, Chattipakorn N
8-oxoguanine: from oxidative damage to epigenetic and epitranscriptional modification